| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 79.38B | 93.07B | 77.78B | 73.80B | 63.30B | 55.68B |
| Gross Profit | 14.15B | 16.22B | 14.31B | 14.93B | 13.93B | 13.96B |
| EBITDA | 1.40B | 2.25B | 1.66B | 1.75B | 1.22B | 1.38B |
| Net Income | 201.00M | 989.00M | 343.00M | 181.00M | 173.00M | 743.00M |
Balance Sheet | ||||||
| Total Assets | 63.45B | 78.52B | 58.36B | 54.83B | 51.77B | 43.43B |
| Cash, Cash Equivalents and Short-Term Investments | 7.13B | 5.28B | 5.08B | 4.67B | 4.12B | 5.44B |
| Total Debt | 10.85B | 17.90B | 8.73B | 5.52B | 3.44B | 399.00M |
| Total Liabilities | 32.30B | 46.26B | 27.27B | 23.86B | 21.23B | 12.94B |
| Stockholders Equity | 30.86B | 31.77B | 30.77B | 30.67B | 30.25B | 30.20B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -5.04B | -2.19B | -489.00M | -3.87B | 401.00M |
| Operating Cash Flow | 0.00 | -3.38B | -1.34B | 481.00M | -3.10B | 861.00M |
| Investing Cash Flow | 0.00 | -5.26B | -1.08B | -1.69B | -973.00M | -727.00M |
| Financing Cash Flow | 0.00 | 8.83B | 2.83B | 1.74B | 2.76B | -466.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥70.58B | 12.01 | ― | 1.55% | 6.02% | 5.87% | |
65 Neutral | ¥206.74B | 11.86 | 13.33% | 3.47% | 3.37% | 5.12% | |
65 Neutral | ¥30.34B | 12.43 | ― | 1.23% | 5.09% | 10.97% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
56 Neutral | ¥48.37B | 14.00 | ― | 1.51% | 3.69% | -34.32% | |
50 Neutral | ¥42.12B | 42.59 | ― | 0.60% | 19.65% | 361.50% | |
49 Neutral | ¥60.52B | 47.36 | ― | 1.14% | 9.13% | -21.27% |